Product Information

TRAVOPROST 0.004% EYE DROP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $8.7821 per ML under NDC 68462094303. Its NADAC has been published 101 times since Dec 18, 2024.

FDA first approved this application on Jul 12, 2024. Its Orange Book therapeutic-equivalence code is AT2.

TRAVOPROST 0.004% EYE DROP

Travoprost Ophthalmic Solution
$8.7821per ML

Strength

.04 mg/mL

NDC

68462094303

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

TRAVOPROST

Approval Type

Generic (ANDA)

FDA Application

ANDA218159

FDA Approved

7/12/2024

TE Code

AT2

On Market Since

9/30/2024

Pharmacological Classes

Prostaglandin Analog
Prostaglandins

Price Statistics

The NADAC for TRAVOPROST 0.004% EYE DROP has been published 101 times since Dec 18, 2024, and over the history we have for it it has declined 40.9%. The table below summarizes its recorded NADAC range and movement.

Current price$8.7821 per ML
All-time high$14.8482 (Jan 15, 2025)
All-time low$7.9822 (Jul 22, 2026)
52-week high$10.4525
52-week low$7.9822
Median price$10.4525
Average price$10.9912
Largest weekly change-10.5% (Sep 17, 2025)
Weeks tracked101
Tracking sinceDec 18, 2024

Price History

1W

+0.9%

1M

+4.6%

3M

+6.3%

6M

+2.8%

1Y

-15.8%

3Y

N/A

5Y

N/A

All

-40.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRAVOPROST 0.004% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TRAVOPROST 0.004% EYE DROP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $8.7821 per ML (NDC 68462094303), effective Nov 18, 2026.

How has the price of TRAVOPROST 0.004% EYE DROP changed over time?

Over the history we have for it, the NADAC for TRAVOPROST 0.004% EYE DROP has declined 40.9%. It has been tracked across 101 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for TRAVOPROST 0.004% EYE DROP?

Since Dec 18, 2024, the NADAC for TRAVOPROST 0.004% EYE DROP has ranged from a low of $7.9822 (Jul 22, 2026) to a high of $14.8482 (Jan 15, 2025), with a median of $10.4525 per ML.

Are there cheaper alternatives to TRAVOPROST 0.004% EYE DROP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRAVOPROST 0.004% EYE DROP, is $8.7425 per ML — about 0% below TRAVOPROST 0.004% EYE DROP.

Who manufactures TRAVOPROST 0.004% EYE DROP?

TRAVOPROST 0.004% EYE DROP (NDC 68462094303) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.